Keywords: gynzyme, buy, bioenvision, co-developed, clofarabine, 345m, deal

Gynzyme to buy Bioenvision - and co-developed clofarabine - in $345M deal

Article | 04 June 2007

Print This

Biotechnology major Genzyme Corp says it has reached to acquire fellow USA-based Bioenvision, in an all-cash transaction of $5.60 a share, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in